Alliance for Clinical Trials in Oncology: Breast Neoplasms trials

The registry lists 85 Breast Neoplasms studies with Alliance for Clinical Trials in Oncology as lead sponsor. 3 are open to participants now and 27 have results posted.

Phase 1 1Phase 2 31Phase 3 32No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize TrialRecruitingNCT05379153Phase 3
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
• Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following MastectomyActive, not recruitingNCT04989504Phase 3Results posted
• Increasing Patients' Engagement in Breast Cancer Surgery Decision-MakingCompletedNCT03766009Not applicableResults posted
• Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerActive, not recruitingNCT03414970Phase 3Results posted
• MRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerCompletedNCT01805076Phase 3Results posted
• Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentCompletedNCT01573442Phase 3Results posted
• Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast CancerCompletedNCT01556243Phase 2Results posted
• Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerCompletedNCT01439945Phase 2Results posted
• Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal SymptomsCompletedNCT01376349Phase 3Results posted
• Vitamin D and Breast Cancer Biomarkers in Female PatientsCompletedNCT01224678Phase 3Results posted
• Panobinostat and Letrozole in Treating Patients With Metastatic Breast CancerCompletedNCT01105312Phase 1/2Results posted
• Brostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT01091454Phase 2Results posted
• Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01086605Phase 2Results posted
• Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen TherapyCompletedNCT00956813Phase 3Results posted
• Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerCompletedNCT00881361Phase 2Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerCompletedNCT00820872Phase 2Results posted
• Cryoablation Therapy in Treating Patients With Invasive Ductal Breast CancerStatus unknownNCT00723294Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00423917Phase 2Results posted
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesCompletedNCT00377156Phase 3Results posted
• Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionCompletedNCT00376597Results posted
• Pilocarpine in Treating Vaginal Dryness in Patients With Breast CancerCompletedNCT00343382Phase 3Results posted
• Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerCompletedNCT00296036Phase 3Results posted
• Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00265759Phase 3Results posted
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
• EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast CancerCompletedNCT00046891Phase 3Results posted
• Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerCompletedNCT00041119Phase 3Results posted
• Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerCompletedNCT00024102Phase 3Results posted
• Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With PaclitaxelActive, not recruitingNCT05751668Phase 2
• Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationActive, not recruitingNCT04711109Phase 3
• Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider InterventionsActive, not recruitingNCT04549571Not applicable
• Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionActive, not recruitingNCT03927027Phase 3
• Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502TerminatedNCT03609021
• Breast Cancer WEight Loss Study (BWEL Study)Active, not recruitingNCT02750826Phase 3
• Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
• Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyActive, not recruitingNCT01901094Phase 3
• Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without TrastuzumabCompletedNCT01562288
• Biomarkers in Tissue Samples From Older Women With Breast CancerTerminatedNCT01346579
• Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871CompletedNCT01015963
• Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741CompletedNCT00991263
• Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27CompletedNCT00968214
• Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast CancerCompletedNCT00899509
• Biomarkers in Native American Women With Breast CancerCompletedNCT00898976
• Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831CompletedNCT00898898
• Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344CompletedNCT00897026
• Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerCompletedNCT00516698
• Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
• Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerCompletedNCT00416689
• Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or AnastrozoleCompletedNCT00316836
• Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerCompletedNCT00275041Phase 2
• Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00265733Phase 2
• Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerCompletedNCT00115505
• Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00107510Phase 2
• Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
• Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00088998Phase 2
• Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone TherapyCompletedNCT00087399Phase 3
• Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00079118Phase 2
• Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast CancerCompletedNCT00068328
• Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast CancerCompletedNCT00060320Phase 3
• Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a TaxaneCompletedNCT00059852Phase 2
• Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerCompletedNCT00054418Phase 3
• Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerWithdrawnNCT00053339Phase 3
• Celecoxib in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00045591Phase 2
• Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWithdrawnNCT00041171Phase 3
• Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer SurgeryCompletedNCT00033397
• Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast DiseaseCompletedNCT00031720Phase 2
• Shark Cartilage in Treating Patients With Advanced Colorectal or Breast CancerCompletedNCT00026117Phase 3
• Vinorelbine in Treating Older Women With Stage IV Breast CancerCompletedNCT00022152Phase 2
• Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast CancerCompletedNCT00022087Phase 3
• ICI 182780 in Treating Women With Metastatic Breast CancerCompletedNCT00012025Phase 2
• Ceramide Cream in Treating Women With Cutaneous Breast CancerCompletedNCT00008320Phase 2
• LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00006007Phase 2
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast CancerCompletedNCT00005963Phase 2
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004893Phase 2
• Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerCompletedNCT00003855Phase 3
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerCompletedNCT00003854Phase 3
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerCompletedNCT00003674Phase 3
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Irinotecan in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00003351Phase 2
• Combination Chemotherapy in Treating Patients With Breast CancerCompletedNCT00003088Phase 3
• Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00002998Phase 2
• Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast CancerCompletedNCT00002762